Director Of 510(k) Pre-Market Notification Staff Makes Her Exit
This article was originally published in The Gray Sheet
Executive Summary
Heather Rosecrans, the long-time head of the 510(k) pre-market review section at FDA's device center, says it's time for her to move on
You may also be interested in...
Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA
Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group
Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA
Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group
People In Brief
FDA 510(k) director joins Greenleaf: Heather Rosecrans Sept. 28 follows former CDRH Director Dan Schultz to the consulting firm Greenleaf Health, where she will serve as a senior regulatory advisor working with Greenleaf clients to advance innovative devices (1"The Gray Sheet" Sept. 20, 2010). Other former FDAers at Greenleaf include former deputy chief of staff Taryn Fritz Warpole and former FDA Commissioner Andrew von Eschenbach. Former FDA Chief of Staff Patrick Ronan founded the Washington, D.C., and Portola Valley, Calif., firm